ABEO logo

ABEO
Abeona Therapeutics Inc

11,019
Mkt Cap
$280.71M
Volume
1.75M
52W High
$7.54
52W Low
$3.93
PE Ratio
4.45
ABEO Fundamentals
Price
$5.40
Prev Close
$5.18
Open
$5.20
50D MA
$5.18
Beta
0.69
Avg. Volume
1.29M
EPS (Annual)
-$1.55
P/B
1.59
Rev/Employee
$0.00
$153.63
Loading...
Loading...

About

Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life-threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB), ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA), and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in Cleveland, OH.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
136

Frequently Asked Questions

What is Market Cap of Abeona Therapeutics Inc?
What is the 52-week high for Abeona Therapeutics Inc?
What is the 52-week low for Abeona Therapeutics Inc?
What is Abeona Therapeutics Inc stock price today?
What was Abeona Therapeutics Inc stock price yesterday?
What is the PE ratio of Abeona Therapeutics Inc?
What is the Price-to-Book ratio of Abeona Therapeutics Inc?
What is the 50-day moving average of Abeona Therapeutics Inc?
How many employees does Abeona Therapeutics Inc have?

Latest ABEO News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.